Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Timing conversions into stablecoins can protect gains during drawdowns. This piece outlines indicators and decision points for choosing pivots.
10,055 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Wednesday brought an outsized move for Sprinklr as earnings beat and optimism around CXM services spurred fresh buyin...
Meta reports rising engineering output amid a larger headcount, fueling a split between efficiency and payroll. The m...
A year of dramatic moves has put Dave (DAVE) on investors' radar. A newly disclosed $7 million stake from a prominent...
Investors are watching limoneira (lmnr) 2026 earnings for clues on citrus demand, real estate activity, and cost mana...
Palantir stock isn't cheap, but its AI-driven data platform and strong government foothold create a long‑term thesis ...
El Pollo Loco shares surged after a solid earnings beat and improving store momentum. This article breaks down the re...
Public appearances in today’s media age can trigger real financial consequences. This article uses Erika Kirk as a co...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
Two memory stock stories illustrate a bigger question for investors: should you chase the momentum that Wall Street r...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
Zoom's post-pandemic growth trajectory remains uncertain as investors weigh AI opportunities and competition. This pi...